Menu
GeneBe

12-79292078-A-T

Variant summary

Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM1PM2PP2

The NM_005639.3(SYT1):c.422A>T(p.Glu141Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)

Consequence

SYT1
NM_005639.3 missense

Scores

1
5
12

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 9.10
Variant links:
Genes affected
SYT1 (HGNC:11509): (synaptotagmin 1) This gene encodes a member of the synaptotagmin protein family. The synaptotagmins are integral membrane proteins of synaptic vesicles that serve as calcium sensors in the process of vesicular trafficking and exocytosis. The encoded protein participates in triggering neurotransmitter release at the synapse in response to calcium binding. Mutations in this gene are associated with Baker-Gordon syndrome. [provided by RefSeq, Jan 2023]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 5 ACMG points.

PM1
In a region_of_interest Phospholipid binding (size 246) in uniprot entity SYT1_HUMAN there are 19 pathogenic changes around while only 0 benign (100%) in NM_005639.3
PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant where missense usually causes diseases, SYT1

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
SYT1NM_005639.3 linkuse as main transcriptc.422A>T p.Glu141Val missense_variant 6/11 ENST00000261205.9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
SYT1ENST00000261205.9 linkuse as main transcriptc.422A>T p.Glu141Val missense_variant 6/111 NM_005639.3 P3

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJun 23, 2023The c.422A>T (p.E141V) alteration is located in exon 7 (coding exon 3) of the SYT1 gene. This alteration results from a A to T substitution at nucleotide position 422, causing the glutamic acid (E) at amino acid position 141 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.093
T
BayesDel_noAF
Benign
-0.37
Cadd
Uncertain
25
Dann
Uncertain
0.98
DEOGEN2
Uncertain
0.43
T;T;.;T;T;T
Eigen
Uncertain
0.41
Eigen_PC
Uncertain
0.53
FATHMM_MKL
Pathogenic
0.99
D
M_CAP
Benign
0.017
T
MetaRNN
Benign
0.33
T;T;T;T;T;T
MetaSVM
Benign
-0.84
T
MutationAssessor
Benign
1.8
L;L;.;L;.;.
MutationTaster
Benign
1.0
D;D;D;D
PrimateAI
Uncertain
0.67
T
PROVEAN
Benign
-1.5
N;N;N;N;N;N
REVEL
Benign
0.15
Sift
Benign
0.31
T;T;T;T;T;T
Sift4G
Benign
0.33
T;T;T;T;T;T
Polyphen
0.017
B;B;.;B;.;.
Vest4
0.39
MutPred
0.41
Gain of catalytic residue at L143 (P = 0.0256);Gain of catalytic residue at L143 (P = 0.0256);.;Gain of catalytic residue at L143 (P = 0.0256);.;Gain of catalytic residue at L143 (P = 0.0256);
MVP
0.10
MPC
0.29
ClinPred
0.75
D
GERP RS
5.7
Varity_R
0.48
gMVP
0.42

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.34
Details are displayed if max score is > 0.2
DS_DG_spliceai
0.34
Position offset: -2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr12-79685858; API